NASDAQ: PRME · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Prime Medicine Inc.

How Prime Medicine Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$950.4M

Price

$5.24

P/E

-5.0

EPS (TTM)

$-1.04

1-year return

28.6%

Dividend yield

0.0%

52-week range

$2.67–$5.24

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources